Alkermes to acquire Boston-based neuroscience company Rodin Therapeutics
Alkermes acquisition of Rodin Therapeutics : Irish biopharma company Alkermes has agreed to acquire Boston-based neuroscience company Rodin Therapeutics in a deal worth up to ... Read More
Levo gets FDA fast track status for LV-101 in Prader-Willi syndrome
US biotech company Levo Therapeutics has been granted fast track designation for LV-101 (intranasal carbetocin) from the US Food and Drug Administration (FDA) for the ... Read More
resTORbio to stop RTB101 development for symptomatic respiratory illness
resTORbio has discontinued the development of RTB101, a TORC1 inhibitor, for the prevention of clinically symptomatic respiratory illness (CSRI) after the drug failed to meet ... Read More
FTC clears decks for Bristol-Myers Squibb acquisition of Celgene
Bristol-Myers Squibb acquisition of Celgene : US pharma giant Bristol-Myers Squibb said that the US Federal Trade Commission (FTC) has given its clearance for its ... Read More
CooperVision MiSight contact lens gets FDA approval to slow down myopia in children
Soft contact lens manufacturer CooperVision has secured approval for its MiSight contact lens from the US Food and Drug Administration (FDA) to slow the progression ... Read More
Novartis bags Adakveo FDA approval to reduce VOCs in sickle cell disease
Adakveo FDA approval : Swiss drugmaker Novartis has bagged approval for Adakveo (crizanlizumab-tmca) from the US Food and Drug Administration (FDA) for its use in ... Read More
Roche to acquire US biotech company Promedior for $1.4bn
Roche acquisition of Promedior : Swiss drugmaker Roche has agreed to acquire Massachusetts-based biotech company Promedior in a deal worth up to $1.39 billion, as ... Read More
Terason, DiA bring AI-based cardiac solutions for ultrasound devices
Terason, a US ultrasound imaging company, has partnered with DiA Imaging Analysis, an artificial intelligence-based solutions provider for ultrasound analysis, to provide cardiac solutions for ... Read More
Merck acquires Calporta Therapeutics from COI Pharmaceuticals
Merck acquisition of Calporta : Merck has acquired Calporta Therapeutics from COI Pharmaceuticals in a deal worth up to $576 million, as per the latest ... Read More
Cancer immunotherapy company EpicentRx raises $35m in Series D round
EpicentRx, a cancer immunotherapy company based in California, has secured $35 million of capital through a Series D financing round to support the development of ... Read More